Global Cancer/Tumor Profiling Market Propelled by
Shift towards Point-of-care Diagnostics
A new report from Transparency Market Research, titled ‘Cancer/Tumor Profiling Market Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,’ states that the
global market is expected to expand steadily from 2013 to 2019 owing to technical
advancements, the rising investments, and the paradigm shift towards point-of-care diagnostics.
Cancer is a disease categorized by uncontrolled cell division. The cell aberration leads to
irregular cell growth, which destroys the surrounding tissues. The disease can be fatal when it
spreads to other vital organs. Cancer diagnosis is done in many ways including medical imaging
and screening tests. As per the WHO, cancer is among the leading causes of death. The disease is
expected to account for around 11.5 million deaths by 2030 across the globe. Profiling of tumors
is carried out to gain knowledge about cancer in patients and also to determine genomic
alterations. This guides doctors and physicians to offer the most appropriate therapy to patients.
Profiling also helps to avoid the use of therapies which are not likely to be successful and also
reduce errors in trial process.
Over the past few years, there has been an increase in the demand for personalized medicine.
Personalized medicines are used in early diagnosis, research applications, and disease prognosis.
With this, the global cancer tumor profiling market is expected to grow at a steady pace in the
years to come. The global cancer tumor profiling market is segmented on the basis of region,
application, segment, and technology. By technology, the global cancer tumor profiling market is
classified into next-generation sequencing, quantitative PCR, immunohistochemistry, and
microarray, and fluorescence/chromogenic in-situ hybridization. Diagnostics, personalized
medicines, prognosis, biomarker discovery, and research are some of the...